Author

PR Conkling

Observed name: P R Conkling

Institutions: Mayo Clinic, Memorial Sloan Kettering Cancer Center, Eli Lilly (United States), Virginia Oncology Associates, Highlands Oncology Group, University of Pittsburgh Medical Center, Moores Cancer Center, UNC Lineberger Comprehensive Cancer Center

Observed institutions: Mayo Clinic, Memorial Sloan Kettering Cancer Center, Eli Lilly (United States), Virginia Oncology Associates, Highlands Oncology Group, University of Pittsburgh Medical Center, Durham VA Medical Center, Moores Cancer Center, UNC Lineberger Comprehensive Cancer Center

OpenAlex ID: A5042859259

Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes

1988 · PR Conkling, CS Greenberg, et al. · Blood · 175

Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain

1987 · LJ Weisberg, DT Shiu, et al. · Blood · 60

Abstract P4-13-25: Abemaciclib, an inhibitor of CDK4 and CDK6, combined with endocrine and HER2-targeted therapies for women with metastatic breast cancer

2016 · MP Goetz, M Beeram, et al. · Cancer Research · 6

Brown blood: understanding methemoglobinemia.

1986 · P R Conkling · PubMed · 3

Works count: 4

Citation count: 244

H-index: 3

I10-index: 2